Fiscal Year (FY) 2023:

Request for Proposals

Pre-Proposal Deadline: January 14, 2022

Posted: October 8, 2021

Faculty International Partnership and Research - Translational Medicine (FIPAR-TMed) Grants

Goal:

The goal of the Faculty International Partnership and Research – Translational Medical (FIPAR-TMed) Program is to facilitate competitive international research collaboration in translational and clinical research. Specifically, the grant will support new and on-going international partnerships focused on translational, pre-clinical, and clinical research involving the processing and histology of human tissue samples or the processing of data for epidemiologic and behavioral studies of disease across all fields of study.  Partners will leverage assets and share existing tissue and/or data samples collected or processes by partners to enhance research resulting in outcomes such as joint publications, joint disease surveillance, joint external grant proposals, training and professional development, faculty and researcher exchanges, and other opportunities.  The overarching goal of this pilot RFA is to enhance interdisciplinary global research capacity, drug discovery, and reduction of health burdens of diseases.

The FIPAR-TMed grant will award up to $10,000 a year to support established* relationships with international researchers.

All eligible faculty members are welcome to submit a pre-proposal. However, full proposals may be submitted by invitation only.

*Established relationships are those where the collaborators have demonstrable , active  collaboration for at least 13 months with a resulting track record of grants and/or publications from the collaboration.

Sponsoring Units:                                       

  • Office of Vice President for Research & Economic Development (OVPRED)
  • Office of International Initiatives (OII)

Submission Deadlines

RFP Opens: Friday, October 8, 2021

Pre-Proposal Submission & Review:

  • Submission: Friday, January 14, 2022
  • Review & Full Proposal Invitation: Friday, January 28, 2022

Full Proposal Deadline: Friday, March 25, 2022

Awards Announcement: Friday, May 13, 2022

Application Procedure

I. Pre-Proposal: (Maximum 500 words – 1.5 pages)

  1. The pre-proposal should provide a brief overview of the project. It should include the project title and answer the questions:
    • what is/are the primary aim(s) of the project (i.e. what question does the project propose to answer)
    • how important is funding this research to improving global health? (i.e. potential impact)
    • how will processing existing tissue samples advance translational and clinical research and outcomes of the project?
    • how will collaboration with the prospective partner facilitate research outcomes?
    • Please review eligibility before applying.
  2. This overview should be no longer than 1 and ½ pages. The text should be understandable at a non-scientist level reviewer. Do not include your name or names of collaborators on the overview document, as this process will include a blind review. Success in this stage will result in an invitation to submit a full proposal.

II. RESEARCH PLAN FOR FULL PROPOSAL: (Conditional upon invitation) (Maximum 2500 words – 5 pages)

The research plan should include details of the proposed project. P.I.s’ should address the following:

  1. Significance of Research Project – specify a disease or health challenge that represents a gap in current knowledge and how access to tissue or data samples will enhance this global research project. Describe the objective(s) of the intended project, identify the collaborator(s), and establish how the research will contribute to / impact institutional and global outcomes. Describe the institutional assets, strengths and challenges of each collaborator and how the collaboration will be beneficial to both.
  2. Background and Significance Discuss the nature and length of the collaborative relationship and how it has facilitated inquiry leading to the intended prospective research. Discuss the scope of work of each partner institution, identify the lead P.I., and how their work will help meet the expected outcomes of the project. Speak to the novelty of the proposed project, if any, and its significance to the reduction of a global health burden.
  3. Research Activities, Capacity, and Outcomes – Outline the project objectives, activities, outcomes, and corresponding timelines. Describe how the research capacity (structure, resources, and skills) at each institution will contribute to the implementation of intended activity(ies). Describe institutional expectations and support from relevant units at each partner institution. These may include agreements and negotiations on transfer protocols, international regulations, and legal considerations. Address how the proposed project will impact research outcomes and capacity of the partners. Address the value of an interdisciplinary approach in accomplishing stated project objectives.
  4. Project Milestones – Establish key project milestones as an indicator of your project duration. If the proposed work is likely to take longer than a year, indicate the total expected time frame. Clearly specify what the applicants hope to accomplish by the end of the project. Individual projects may not exceed two fiscal years. Updates on these milestones will be captured through semi-annual reports requirements.
  5. Participants List each participant and the corresponding strengths and skills each one will contribute to interdisciplinarity and the success of the project. (See Appendices for additional guidance on bio-sketches). 

III. BUDGET AND BUDGET JUSTIFICATION:

On a separate page, outline and justify financial support your project. A thorough justification is needed for all expenses. Please note:

  • No funding is allowed for Principal Investigator or Co-Investigator Salary.
  • No funding will be provided for books and subscriptions, membership fees, or graduate students. These could originate from and be considered departmental or college cost-share.
  • Training and access fees will be considered on a case by case basis for participants from developing countries. These may include membership, subscription or conference fees for the duration of the project.

IV. SUSTAINABILITY: To sustain global research collaborations, collaborators are expected to jointly seek external funding, publish, present, and engage in professional development. Each research plan is expected to address how it will sustain its collaboration and activities to the extent that it may develop into a strategic partnership*. Where a sustainability activity involves seeking external funds, P.I. should include critical information such as title of grant or RFP, amount, duration, deadline, and sponsor.

*“A strategic partnership at Georgia State is a collaboration with an international institution characterized by active, substantive programming, and evidenced by multiple sustained activities supported by institutional leadership and resources.”

Eligibility Criteria:

  1. Lead P.I.’s for this pilot program must be classified as full-time tenured or tenure-track faculty, i.e., GSU faculty with a contract that specifies a minimum of 40% of their effort towards research.
  2. Have established international collaboration for > 1 year, including some record of grants and/or publications.
  3. Provide evidence of a commitment of additional funds or cost-share to support this collaboration from the collaborating PIs' institutions or other relevant sources.
  4. Have an active research program (e.g. laboratory, access to clinical setting) in which the research activities outlined in the proposal can be completed, if the proposed project involves clinical and translational research with basic research components. See Letter of Support section in Appendices for additional information.

Applications should adhere to the following formatting specifications:

  • Maximum is 5 pages for sections 1-5
  • 11‐point Arial font
  • Single‐spaced
  • 0.5 in margins on all sides
  • 8 ½" x 11" (i.e. standard size) paper
  • Number all pages

Appendices (These do not count towards the 5 page proposal requirement):

V. LITERATURE CITED: Provide a short list (not more than 15) of applicable literature citations. Literature citations will not be in the 5-page limit for the application.

VI. RELEVANT RESEARCH OR PARTNERSHIP AGREEMENTS/ CONTRACTS: Include letters verifying these arrangements or append agreements.

VII. BIOGRAPHICAL SKETCHES: Not to exceed half a page for each participant.

VIII. PRIOR OVPRED/OII FUNDING (IF APPLICABLE):
If applicable, list support and outcomes from prior OVPRED or OII funding.

IX. TRANSFER PROTOCOL OF HUMAN SPECIMEN (IF APPLICABLE):

1. For projects involving human subjects in Year 1, proof of IRB approval or exemption should be included in the Phase 2 application. This proof should include 1) the complete clinical research protocol and 2) any informed consent or assent documents.

a. If the entire parent protocol is included in the submission, please identify the specific portion of the protocol that will be supported by the FIPAR-TMed grant

b. If the proposed protocol is considered an amendment to a parent protocol, provide an explanation of exactly what is being supported by FIPAR-TMed grant

c. To meet the FIPAR-TMed application deadline, the P.I. may provide evidence of IRB submission pending approval.

2. These applications should also include plans for the development of specific human subjects’ research studies. where such studies will only be initiated after some preliminary projects are completed (e.g., development of instruments or compounds, or prior animal studies).

3. If human subject requirements are not applicable to this project, or not applicable until Year 2, please clearly indicate this.

X. LETTERS OF SUPPORT: The GSU P.I. must submit individual letters of support from GSU and partner deans. The letters from the deans must outline the institutional and global importance of the project, the need for this pilot funding, and other resources, including access to labs and cost-share, that are available to the PI in support of the project. The letter must also provide a statement of the protected time needed to perform the pilot study.

Submission Instructions:

  • Send applications to partnerships@gsu.edu
  • Pre-proposal Submission deadline: Friday, January 14, 2022
  • You will receive a confirmation email within 24 hours of submission.
  • If you have any questions or need to update or withdraw a submission, please contact partnerships@gsu.edu prior to deadline.

Review Process:

A review committee and steering committee will be convened by OVPRED and OII. The committee will score the proposals and make recommendations for FIPAR-TMed funding.

Scoring Criteria:

Scoring will evaluate: Project significance, Approach, Innovation, Feasibility, Collaboration and Global Impact.

Funding & Compliance Requirements:

Funded projects are required to submit brief semi-annual progress reports as well as a final report. Investigators must acknowledge FIPAR-TMed funding in all publications and presentations. Investigators will also be expected to participate in selected activities with OVPRED and OII such as presentations and review of future applications.  

Principal Investigators (PIs) are responsible for ensuring that activities conducted under the program follow all applicable federal, state and university policies.  Upon receiving a Notice of Award for a FIPAR-TMed grant, the P.I. is responsible for submitting all compliance protocols required for their project as soon as possible (e.g., IRB, use of human subjects, use of animal subjects, use of radioactivity, bio-hazardous or hazardous materials). P.I.s must receive official compliance approval before they can be given access to their grant funds and begin work on their project under the award. A prolonged delay in obtaining appropriate compliance approvals that significantly delays the work on the project may result in cancellation of the award at such a time deemed appropriate by OVPRED and OII in consultation with the Principal Investigator, if it is determined that the project cannot be completed within the time remaining on the award budget period.